1.
Nurs Clin North Am
; 58(2): 165-181, 2023 06.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37105652
RESUMEN
In the United States, the opioid epidemic and COVID-19-related substance use have exacerbated the overall incidence of substance use disorders (SUDs). Medication-assisted therapy (MAT), or cognitive and behavioral therapy that combines medications that reduce substance use or acute withdrawal symptoms, has dramatically improved outcomes for SUD patients, including preventing mortality. With recent US Congressional funding for MAT, patients presenting for acute care on MAT-related medications will continue to increase. Nurses should be aware of these medications' mechanism of action, typical side effects, and implications on treating acute pain to optimize their care.
Asunto(s)
COVID-19 , Trastornos Relacionados con Opioides , Trastornos Relacionados con Sustancias , Humanos , Estados Unidos , Terapia Conductista , Trastornos Relacionados con Opioides/tratamiento farmacológico
2.
J Am Acad Dermatol
; 89(6): 1245-1246, 2023 12.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36813135